Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 10, Issue 8, Pages 1581-1590
Publisher
Wiley
Online
2012-05-26
DOI
10.1111/j.1538-7836.2012.04790.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
- (2011) E. K. Waters et al. BLOOD
- Tissue factor pathway inhibitor: structure-function
- (2011) George et al. Frontiers in Bioscience-Landmark
- Standardization of thromboelastography: a report from the TEG-ROTEM working group
- (2011) M. CHITLUR et al. HAEMOPHILIA
- Management of acquired haemophilia A
- (2011) P. W. COLLINS JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
- (2011) A. GRINGERI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation
- (2011) L. A. PARUNOV et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
- (2011) Cindy Leissinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
- (2010) Petra Paulinska et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
- (2010) Bernd Jilma et al. THROMBOSIS AND HAEMOSTASIS
- The Role of Tissue Factor and Factor VIIa in Hemostasis
- (2009) Nigel Mackman ANESTHESIA AND ANALGESIA
- Mild hemophilia A
- (2009) M. FRANCHINI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study
- (2009) P. COLLINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens
- (2009) P. W. COLLINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland
- (2008) Andreas Tiede et al. ANNALS OF HEMATOLOGY
- A survey of adherence to haemophilia therapy in six European countries: results and recommendations
- (2008) P. DE MOERLOOSE et al. HAEMOPHILIA
- Haemophilia care then, now and in the future
- (2008) J. OLDENBURG et al. HAEMOPHILIA
- Extending half-life in coagulation factors: where do we stand?
- (2008) David Lillicrap THROMBOSIS RESEARCH
- Nanotechnology and aptamers: applications in drug delivery
- (2008) Etgar Levy-Nissenbaum et al. TRENDS IN BIOTECHNOLOGY
- Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A
- (2007) S. Prasad et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started